142 related articles for article (PubMed ID: 19596117)
21. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
22. [Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases].
Meijer S; Torrenga H; van der Sijp JR
Ned Tijdschr Geneeskd; 2002 May; 146(20):942-6. PubMed ID: 12051063
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H
Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
[TBL] [Abstract][Full Text] [Related]
25. Is sentinel lymph node biopsy after neoadjuvant chemotherapy feasible in Chinese patients with invasive breast cancers?
Cheung TT; Suen DT; Kwong A
ANZ J Surg; 2009 Oct; 79(10):719-23. PubMed ID: 19878167
[TBL] [Abstract][Full Text] [Related]
26. False-negative sentinel lymph node biopsy.
van Wely BJ; Smidt ML; de Kievit IM; Wauters CA; Strobbe LJ
Br J Surg; 2008 Nov; 95(11):1352-5. PubMed ID: 18844270
[TBL] [Abstract][Full Text] [Related]
27. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.
D'Eredita' G; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
Breast; 2007 Jun; 16(3):316-22. PubMed ID: 17293114
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
[TBL] [Abstract][Full Text] [Related]
30. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
32. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
33. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
34. Non-axillary breast cancer recurrences after sentinel node biopsy.
van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
[TBL] [Abstract][Full Text] [Related]
35. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH
Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602
[TBL] [Abstract][Full Text] [Related]
38. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.
Liukkonen S; Saarto T; Mäenpää H; Sjöström-Mattson J
Acta Oncol; 2010 Apr; 49(3):322-7. PubMed ID: 20397767
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients.
van Wessem KJ; Meijer WS
Breast; 2004 Aug; 13(4):290-6. PubMed ID: 15325663
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer.
Morcos B; Jaradat I; El-Ghanem M
Eur J Surg Oncol; 2011 May; 37(5):418-21. PubMed ID: 21316187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
